Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.
Funding Rounds (6) - $75.44MUpdate
Current Team (10)Update
Board Members and Advisors (4)Update
One Kendall Square,
Cambridge, Massachusetts 02139